풀매트릭스 (PULM) 주가

풀매트릭스(PULM)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.44 (+0.50%), 시가총액 $0.00B, 52주 최저~최고 $1.19 ~ $9.09.

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis;

핵심 지표

• 현재가: $1.44 (+0.50%)
• 시가총액: $0.00B
• 52주 최저~최고: $1.19 ~ $9.09
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

풀매트릭스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

풀매트릭스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.19
• 순이익률: 0.00%
• 영업이익률: 0.00%

자주 묻는 질문